Finance

Lists
RMD:ASX
Resmed CDI
34,96 AUD
+1,42%
(+0,49) 1D
13 ნოე, 16:10:12 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RMD...
Open
34,85 AUD
High
35,14 AUD
Low
34,81 AUD
Mkt. cap
33,69 მლრდ.
Avg. vol.
1,76 მლნ.
Volume
744,13 ათ.
52-wk high
39,94 AUD
52-wk low
25,50 AUD
Shares outstanding
140,66 მლნ.
No. of employees
11 ათ.
Open
34,85 AUD
High
35,14 AUD
Low
34,81 AUD
Mkt. cap
33,69 მლრდ.
Avg. vol.
1,76 მლნ.
Volume
744,13 ათ.
52-wk high
39,94 AUD
52-wk low
25,50 AUD
Shares outstanding
140,66 მლნ.
No. of employees
11 ათ.
News stories
From web sources and news partners
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed CDI
CEOმაიკლ ჯეი ფარელ
Employees11,4 ათ.
Foundedივნ 1989
Headquartersსან-დიეგო, კალიფორნია, ამერიკის შეერთებული შტატები
SectorHealth Care
IndustryMedical device
Websiteresmed.com
Last report
29 ოქტ. 2026
Fiscal period
Q1 2027
0,29 US$ / 0,27 US$
+8,81%beat
Revenue / Est. (USD)
1,41 მლრდ. / 1,39 მლრდ.
+1,55%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
1,42 მლრდ.
1,43 მლრდ.
1,46 მლრდ.
1,41 მლრდ.
Cost of goods sold
536,28 მლნ.
532,58 მლნ.
594,13 მლნ.
536,45 მლნ.
Cost of revenue
536,28 მლნ.
532,58 მლნ.
594,13 მლნ.
536,45 მლნ.
Research and development expenses
90,97 მლნ.
94,27 მლნ.
105,72 მლნ.
101,53 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
275,70 მლნ.
279,80 მლნ.
293,36 მლნ.
284,20 მლნ.
Operating expense
386,24 მლნ.
393,16 მლნ.
417,88 მლნ.
385,73 მლნ.
Total operating expenses
922,51 მლნ.
925,74 მლნ.
1,01 მლრდ.
922,18 მლნ.
Operating income
500,30 მლნ.
505,67 მლნ.
451,64 მლნ.
492,64 მლნ.
Other non operating income
42,00 ათ.
181,00 ათ.
4,40 მლნ.
2,95 მლნ.
EBT including unusual items
496,15 მლნ.
502,31 მლნ.
474,16 მლნ.
539,16 მლნ.
EBT excluding unusual items
504,48 მლნ.
518,30 მლნ.
476,09 მლნ.
511,31 მლნ.
Income tax expense
103,56 მლნ.
103,58 მლნ.
90,73 მლნ.
120,74 მლნ.
Effective tax rate
20,87%
20,62%
19,14%
22,39%
Other operating expenses
-
-
-
-
Net income
392,59 მლნ.
398,73 მლნ.
383,43 მლნ.
418,41 მლნ.
Net profit margin
27,59%
27,86%
26,20%
29,57%
Earnings per share
2,81
0,29
0,30
0,29
Interest and investment income
4,46 მლნ.
3,80 მლნ.
31,76 მლნ.
21,20 მლნ.
Interest expense
-
-
-
-4,81 მლნ.
Net interest expenses
4,46 მლნ.
3,80 მლნ.
31,76 მლნ.
16,38 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
543,79 მლნ.
558,22 მლნ.
490,13 მლნ.
534,38 მლნ.
Gain or loss from assets sale
-
-
-
-61,78 მლნ.
Upcoming events
AI content may include mistakes. Learn more
Google აპები